Stock Details
AMGN is Amgen Inc.'s stock. Stock exchange NasdaqGS (Currency USD). Average price in 50 days is 244.58$. Average daily volumn in 3 months 3.3M. Market cap 131.08B



Stock symbol : AMGN. Exchange : NasdaqGS. Currency : USD
Lastest price : 245.37$. Total volume : 4.53M. Market state CLOSED
Click reload if you want to check the lastest price on market!!!

Amgen Inc. (AMGN)
Last Price
245.37$
Change
2.28
Volume
4.53M

Previous Close243.09
Open244.00
Day Range242.88-246.00
Bid243.13 x 900
Ask245.16 x 800
Volume4.53M
Average Volume3.3M
Market Cap131.08B
Beta0.57
52 Week Range198.64-258.45
Trailing P/E24.25
Foward P/E12.93
Dividend (Yield %)3.25%
Ex-Dividend Date2022-05-16



Financial Details


According to Amgen Inc.'s financial reports the company's revenue in 2021 were 25.98B an increase(0%) over the years 2020 revenue that were of 25.42B. In 2021 the company's total earnings were 5.89B while total earnings in 2020 were 7.26B(-28.57%).


Loading ...



Organization

Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces the chance of infection due a low white blood cell count in patients cancer; Prolia to treat postmenopausal women with osteoporosis; Xgeva for skeletal-rel... ated events prevention; Otezla for the treatment of adult patients with plaque psoriasis, psoriatic arthritis, and oral ulcers associated with Behรงet's disease; Aranesp to treat a lower-than-normal number of red blood cells and anemia; KYPROLIS to treat patients with relapsed or refractory multiple myeloma; and Repatha, which reduces the risks of myocardial infarction, stroke, and coronary revascularization. It also markets Nplate, Vectibix, MVASI, Parsabiv, EPOGEN, KANJINTI, BLINCYTO, Aimovig, EVENITY, AMGEVITATM, Sensipar/Mimpara, NEUPOGEN, IMLYGIC, Corlanor, and AVSOLA. Amgen Inc. serves healthcare providers, including physicians or their clinics, dialysis centers, hospitals, and pharmacies. It distributes its products through pharmaceutical wholesale distributors, as well as direct-to-consumer channels. It has collaboration agreements with Novartis Pharma AG; UCB; Bayer HealthCare LLC; BeiGene, Ltd.; Eli Lilly and Company; Datos Health; and Verastem, Inc. to evaluate VS-6766 in combination with lumakrastm (Sotorasib) in patients with KRAS G12C-mutant non-small cell lung cancer. It has an agreement with Kyowa Kirin Co., Ltd. to jointly develop and commercialize KHK4083, a Phase 3-ready anti-OX40 fully human monoclonal antibody for the treatment of atopic dermatitis and other autoimmune diseases; and research and development collaboration with Neumora Therapeutics, Inc. and Plexium, Inc. Amgen Inc. was incorporated in 1980 and is headquartered in Thousand Oaks, California.

Market Cap:
131.08B
Revenue:
25.98B
Total Assets:
61.16B
Total Cash:
7.99B



News about "Amgen Inc."

amgen-nasdaqamgn-earns-outperform-rating-from-oppenheimer-image

Amgen (NASDAQ:AMGN) Earns โ€œOutperformโ€ Rating from Oppenheimer

Source from : Defense World - 1 days ago

Oppenheimer reiterated their outperform rating on shares of Amgen (NASDAQ:AMGN โ€“ Get Rating) in a research note issued to investors on Friday. They currently have a $290.00 price target on the medical ...See details»


amgen-inc-nasdaqamgn-shares-sold-by-pure-financial-advisors-llc-image

Amgen Inc. (NASDAQ:AMGN) Shares Sold by Pure Financial Advisors LLC

Source from : Defense World - 3 days ago

Pure Financial Advisors LLC lessened its stake in Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) by 12.4% in the 1st quarter, Holdings Channel reports. The firm owned 1,630 shares of the medical research ...See details»


biotech-firm-amgen-lays-out-plans-for-its-humiras-biosimilar-image

Biotech firm Amgen lays out plans for its Humiraโ€™s biosimilar

Source from : The Financial Express on MSN.com - 2 days ago

Europe's first approved biosimilar came in, and after 15 more received approval. However, in the eight years after the first U.S. biosimilar launch (2015), 36 have been approved and 22 have launched, ...See details»


Amgen Inc Among Leading Companies in the Male Infertility Pipeline Products Market | Globaldata Plc

Source from : YAHOO!Finance - 2 days ago

Male infertility refers to a male's inability to achieve a pregnancy in a fertile femaleLONDON, June 23, 2022 (GLOBE NEWSWIRE) -- Male infertility is caused due to low sperm production, immobile sperm ...See details»


fridays-top-analyst-upgrades-and-downgrades-amgen-carmax-ge-home-depot-marathon-digital-metlife-palantir-realty-income-wework-and-more-image

Friday's Top Analyst Upgrades and Downgrades: Amgen, CarMax, GE, Home Depot, Marathon Digital, MetLife, Palantir, Realty Income, WeWork and More

Source from : 24/7 Wall St - 1 days ago

Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding new ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy. Other ...See details»


Amgen Inc. (NASDAQ:AMGN) Given Consensus Recommendation of โ€œHoldโ€ by Brokerages

Source from : ETF Daily News - 25 days ago

Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) has earned a consensus rating of โ€œHoldโ€ from the eighteen brokerages that are covering the company, MarketBeat reports. One investment analyst has rated ...See details»


Amgen Inc. (AMGN) Management Presents at Goldman Sachs 43rd Annual Global Healthcare Conference

Source from : Seeking Alpha - 10 days ago

Goldman Sachs 43rd Annual Global Healthcare Conference June 15, 2022 4:40 PM ET Company Participants Peter Griffith - Executive Vice President, ...See details»


Amgen Drug Gets Second FDA Nod

Source from : sfvbj - 6 days ago

The U.S. Food and Drug Administration has approved Amgen Inc.โ€™s Riabni in combination with chemotherapy drug methotrexate for adults with moderate to severely active rheumatoid arthritis (RA) who have ...See details»


Amgen launches podcast series

Source from : MM&M - 1 days ago

While the podcast aims to reach scientists, Deshaies and Russell explain AI and machine learning in a way most interested parties could understand. Amgen has developed an AI that ...See details»


Did Mirati Therapeutics Just Leapfrog Amgen?

Source from : TheStreet.com - 18 days ago

While there are multiple types of KRAS mutations, Amgen (AMGN) - Get Amgen Inc. Report made history in 2021 by earning the first approval for this high-value target that was once considered ...See details»


amgen-foundation-invests-additional-30m-in-labxchange-image

Amgen Foundation Invests Additional $30M in LabXchange

Source from : sfvbj - 5 days ago

Learn about The Amgen Foundation investing further into online science education platform LabXchange with a $30 million donation.See details»


Oppenheimer Weighs in on Amgen Inc.โ€™s FY2026 Earnings (NASDAQ:AMGN)

Source from : ETF Daily News - 23 days ago

Amgen Inc. (NASDAQ:AMGN โ€“ Get Rating) โ€“ Equities research analysts at Oppenheimer upped their FY2026 earnings per share estimates for shares of Amgen in a research report issued on Tuesday ...See details»


Top Research Reports for Microsoft, Amgen & Honeywell

Source from : Nasdaq - 11 days ago

The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft Corporation (MSFT), Amgen ...See details»


fridays-top-analyst-upgrades-and-downgrades-amgen-autozone-boeing-dollar-general-etsy-fedex-unity-software-warner-bros-discovery-and-more-image

Friday's Top Analyst Upgrades and Downgrades: Amgen, AutoZone, Boeing, Dollar General, Etsy, FedEx, Unity Software, Warner Bros. Discovery and More

Source from : 24/7 Wall St - 8 days ago

Wall St. reviews dozens of analyst research reports each day of the week with a goal of finding fresh ideas for investors and traders alike. Some of these daily analyst calls cover stocks to buy.See details»